A digital platform to reduce suicide risk in at-risk youth
Official title: Development and Testing of a Digitally Assisted Risk Reduction Platform for Youth at High Risk for Suicide
Run by Ksana Health · NCT05920252 · Data updated 2026-11-12
This study is testing a new digital platform called Vira to see if it can help reduce suicide risk in teens aged 13-18 who are getting treatment for mental health issues.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 13 Years to 18 Years |
| Sex | All |
| Enrollment | 78 (estimated) |
| Sponsor | Ksana Health Industry-sponsored |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | August 14, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | March 4, 2026 |
| Trial ID | NCT05920252 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adolescents aged 13-18 who are currently receiving treatment at the Intensive Adolescent and Family DBT Program and own a personal smartphone.
✕Probably not a fit
Patients who require a higher level of care or those already assigned a clinician in the program may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to address the rising rates of youth suicide by developing a digital platform called Vira, which integrates mobile sensing data and HIPAA-compliant communication tools for practitioners. The study will conduct a randomized controlled trial involving 200 adolescents aged 13-18 who are receiving treatment at the Intensive Adolescent and Family DBT Program. Participants will be divided into two groups: one using the Vira platform and the other receiving standard treatment. The goal is to evaluate whether the use of this digital platform improves clinical outcomes for youth at risk of suicide.
Why it matters
Potential benefit: If successful, this platform could significantly enhance the effectiveness of suicide prevention strategies for at-risk youth.
How similar studies have gone: Other studies have shown promise in using digital tools for mental health interventions, suggesting potential success for this novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Written informed assent from adolescents ages 13-17 years old and permission from legal guardians, or consent from adolescents age 18 years old. * Receiving treatment at the Intensive Adolescent and Family DBT Pgogram * 13-18 years old * Owns a personal smartphone (Android or iPhone 7+) * Fluent in English Exclusion Criteria: * Adolescents who require a higher level of care (i.e., are not admitted to the Intensive Outpatient DBT program) * Adolescents who are receiving treatment at the Intensive Adolescent and Family DBT program and have already been assigned a clinician
Where it's running
-
Columbia University
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Nick Allen, PhD — Ksana Health
- Study coordinator: Randy Auerbach, PhD, ABPP
- Email: rpa2009@cumc.columbia.edu
- Phone: 646-774-5745
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Just-in-time Safety Planning for suicidal youths using ViraSafe
This study tests whether the ViraSafe app, an enhanced version of the BRITE safety planning tool, helps suicidal youths engage with coping skills and safety planning more than the original app.
-
Can tACS modulate motivation and reward signals in cannabis use disorder and depression
We’re testing whether a gentle brain stimulation method (tACS) can boost motivation and reward responses in adults with cannabis use and/or depression to see if it helps with anhedonia.
-
Friends and family training for those at risk of suicide
A six-week program tests whether training for caregivers can help them support a loved one at risk of suicide while also taking care of their own mental health.
-
iTBS to help anhedonia in depression (dual left DLPFC + OFC or left DLPFC alone)
A brain stimulation study tests whether intermittent theta burst stimulation can help people with major depression who have anhedonia, using both dual-target (left DLPFC and OFC) and single-target (left DLPFC) approaches.
-
How GLP-1 medicines affect happiness and emotional eating in people with obesity
This study follows adults starting GLP-1 weight-loss therapy to see how their feelings of pleasure and emotional eating change over 6 months.
-
Honest, Open, Proud for justice-involved veterans
This trial tests a peer-delivered stigma-reduction program for veterans with co-occurring mental health or substance use disorders who are involved with the justice system, to see if different delivery intensities help more veterans engage in care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.